Delivery Order SPE2DB22D3301-SPE2DB25FZ0VG
Award Date 9/11/25
Potential Completion Date 10/2/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $11,435.46 delivery order to AmerisourceBergen Drug Corp for Yervoy 50 mg/10 mL vials. This delivery order, issued on September 4, 2025, represents a competitive, non-set-aside award with firm fixed pricing and an ultimate completion date of September 25, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. Yervoy is an immunotherapy medication used in cancer treatment, reflecting the Defense...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Yervoy (ipilimumab) 50 mg/10 mL vials, with a contract ceiling value of $11,435.46. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Department of Defense's Medical Supply Chain awarded a $22,957.99 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Yervoy 200 mg/40 mL vials. This competitive award, with an ultimate completion date of August 19, 2025, represents a firm fixed-price contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. Yervoy (ipilimumab) is an immunotherapy...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Yervoy 50 mg/10 ml vial (10 ml), a prescription medication, with a ceiling value of $22,870.92. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 7, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Yervoy 50 mg/10 ml vials, a specialized cancer medication. The contract has a ceiling value of $11,435.46 and a period of performance ending on May 29, 2025. The contract is a firm fixed-price, non-set-aside arrangement, indicating open competition. AmerisourceBergen Drug Corp...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of YERVOY 50 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $22,870.92 and a period of performance through June 12, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Yervoy 50 mg/10 ml vials, a medication used for the treatment of certain types of cancer. The contract has a firm fixed price and a ceiling value of $22,870.92. It is a non-set-aside contract, indicating open competition. The contract has an ultimate completion date of May 6, 2025 and was awarded on April...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide YERVOY 50 MG/10 ML VIAL 10ML. The $11,435.46 Firm Fixed Price Delivery Order contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This is a $11,435.46 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of YERVOY 50 MG/10 ML VIAL 10ML, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of April 2, 2025 and was awarded on March 12, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563875830 YERVOY 50 MG/10 ML VIAL 10ML, a specialty pharmaceutical product. The delivery order has a potential value of $18,459.12 and a completion date of March 27, 2024. This order is placed under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and...